BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
215 hedge funds and large institutions have $1.45B invested in BioTelemetry, Inc. in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 84 reducing their positions, and 24 closing their positions.
38% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 24
15% more capital invested
Capital invested by funds: $1.26B → $1.45B (+$189M)
11% more call options, than puts
Call options by funds: $14.4M | Put options by funds: $12.9M
3% more funds holding
Funds holding: 209 → 215 (+6)
14% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 84
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14.3M |
| 2 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$8.07M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$5.88M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.56M |
| 5 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
+$3.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$18.8M |
| 2 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$16.1M |
| 3 |
Man Group
London,
United Kingdom
|
-$5.68M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$4.54M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.75M |
BEAT Hedge Fund Activity: Q2 2020 in Review
215 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q2 2020, worth a combined $1.45B — up 15% from $1.26B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new BEAT positions and 24 closed out — a net gain of 9 holders — while 72 added to existing stakes and 84 trimmed.
The largest buyer was BlackRock, adding an estimated $14.3M. The largest seller was Eagle Asset Management, exiting entirely with an estimated $18.8M sold.
- 215 institutional investors held BioTelemetry, Inc. (BEAT) as of Q2 2020, up from 209 in Q1 2020.
- Funds reported $1.45B of BioTelemetry, Inc. stock for Q2 2020, up 15% quarter-over-quarter.
- 33 funds opened new BioTelemetry, Inc. positions in Q2 2020 and 24 closed out, a net change of +9 holders.
- The largest BioTelemetry, Inc. buyer in Q2 2020 was BlackRock, an estimated $14.3M added.
- The largest BioTelemetry, Inc. seller in Q2 2020 was Eagle Asset Management, an estimated $18.8M sold.
Based on aggregated 13F filings for Q2 2020.